Zarogoulidis Paul, Pataka Athanasia, Terzi Eirini, Hohenforst-Schmidt Wolfgang, Machairiotis Nikolaos, Huang Haidong, Tsakiridis Kosmas, Katsikogiannis Nikolaos, Kougioumtzi Ioanna, Mpakas Andreas, Zarogoulidis Kostas
Pulmonary Department-Oncology Unit, "G. Papanikolaou" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece;
J Thorac Dis. 2013 Sep;5 Suppl 4(Suppl 4):S407-12. doi: 10.3978/j.issn.2072-1439.2013.08.15.
Lung cancer still remains the leading cause of cancer death among males. Several new methodologies are being used in the everyday practise for diagnosis and staging. Novel targeted therapies are being used and others are being investigated. However; early diagnosis still remains the cornerstone for efficient treatment and disease management. Lung cancer patients requires in many situations intensive care unit (ICU) admission, either due to the necessity for supportive care until efficient disease symptom control (respiratory distress due to malignant pleural effusion) or disease adverse effect management (massive pulmonary embolism). In any case guidelines indicating the patient that has to be intubated have not yet been issued. In the current review we will present current data and finally present an algorithm based on the current published information for lung cancer patients that will probably benefit from admission to the ICU.
肺癌仍是男性癌症死亡的主要原因。日常诊断和分期中正在使用几种新方法。新型靶向治疗正在应用,其他治疗方法也在研究中。然而,早期诊断仍然是有效治疗和疾病管理的基石。肺癌患者在许多情况下需要入住重症监护病房(ICU),这要么是因为在有效控制疾病症状(恶性胸腔积液导致的呼吸窘迫)之前需要支持治疗,要么是因为要处理疾病的不良反应(大面积肺栓塞)。无论如何,尚未发布关于哪些患者必须插管的指南。在当前的综述中,我们将展示现有数据,并最终根据目前已发表的信息,为可能受益于入住ICU的肺癌患者提出一种算法。